Cuba's Center for Molecular Immunology (CIM) has patented a new lung cancer vaccine, CIM researcher Ana Maria Vazquez said Monday. Vazquez said the antibody, called Racotumomab, was proven in clinical trials this year to increase survival rates among cancer patients, and has shown good safety and tolerance levels. The vaccine combats lung carcinoma by promoting the death of cancer cells and minimizing the presence of tumors, Vazquez explained. Racotumomab is the second vaccine developed by CIM against lung cancer,after CIMAvax EGF, which has proven effective in helping Cuban patients. Lung cancer is the second-most common type of cancer in Cuba with an estimated 5,000 patients in advanced stages of the disease.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor